Active energy ray curable composition, stereoscopic modeling material, active energy ray curable ink, inkjet ink, active energy ray curable composition container, two-dimensional or three-dimensional image forming apparatus, two-dimensional or three-dimensional image forming method, cured product, and processed product

US9790381B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9790381-B2
Application numberUS-201615081326-A
CountryUS
Kind codeB2
Filing dateMar 25, 2016
Priority dateMay 8, 2015
Publication dateOct 17, 2017
Grant dateOct 17, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An active energy ray curable composition is provided. The active energy ray curable composition includes polymerizable compounds including a first monofunctional monomer having a polar group, a second monofunctional monomer having no polar group, and a polyfunctional monomer. The homopolymer of each of the first monofunctional monomer and the second monofunctional monomer has a glass transition temperature of 50° C. or more. The first monofunctional monomer and the second monofunctional monomer account for 50% by mass or more of the polymerizable compounds in total, and the polyfunctional monomer accounts for 30% by mass or less of the polymerizable compounds.

First claim

Opening claim text (preview).

What is claimed is: 1. An active energy ray curable composition, comprising: polymerizable compounds including: a first monofunctional monomer having a polar group; a second monofunctional monomer having no polar group; and a polyfunctional monomer, wherein the homopolymer of each of the first monofunctional monomer and the second monofunctional monomer has a glass transition temperature of 50° C. or more, wherein the first monofunctional monomer and the second monofunctional monomer account for 50% by mass or more of the polymerizable compounds in total, and the polyfunctional monomer accounts for 30% by mass or less of the polymerizable compounds, wherein the first monofunctional monomer has an acrylate group and an atomic group other than hydrocarbon, the second monofunctional monomer has an acrylate group but no other atomic group other than hydrocarbon, and the polyfunctional monomer is a urethane acrylate oligomer, wherein the polymerizable compounds further include a third monofunctional monomer, wherein the homopolymer of the third monofunctional monomer has a glass transition temperature of less than 50° C., and wherein the third monofunctional monomer accounts for 10% to 30% by mass of the polymerizable compounds. 2. The active energy ray curable composition of claim 1 , wherein a cured product of the active energy ray curable composition has a stretchability of 50% or more at 180° C., the stretchability being defined by the following formula: ( L 2− L 1)/ L 1 wherein L1 represents a first length of the cured product before a tensile test and L2 represents a second length of the cured product after the tensile test. 3. The active energy ray curable composition of claim 1 , wherein a mass ratio of the first monofunctional monomer having a polar group to the second monofunctional monomer having no polar group ranges from 0.33 to 3.0. 4. The active energy ray curable composition of claim 1 , wherein the homopolymer of each of the first monofunctional monomer and the second monofunctional monomer has a glass transition temperature of 90° C. or more. 5. The active energy ray curable composition of claim wherein the first monofunctional monomer includes at least one member selected from the group consisting of acrylamide compounds and methacrylamide compounds. 6. The active energy ray curable composition of claim 1 , wherein the second monofunctional monomer includes an alicyclic acrylate or an alicyclic methacrylate. 7. A stereoscopic modeling material, comprising: the active energy ray curable composition of claim 1 . 8. An active energy ray curable ink, comprising: the active energy ray curable composition of claim 1 . 9. An inkjet ink, comprising: the active energy ray curable ink of claim 8 . 10. An active energy ray curable composition container, comprising: a container; and the active energy ray curable composition of claim 1 contained in the container. 11. A two-dimensional or three-dimensional image forming apparatus, comprising: an emitter to emit an active energy ray to the active energy ray curable composition of claim 1 ; and a container containing the active energy ray curable composition of claim 1 . 12. A two-dimensional or three-dimensional image forming method, comprising: emitting an active energy ray to the active energy ray curable composition of claim 1 to cause the active energy ray composition to cure. 13. A cured product, produced by a method comprising: emitting an active energy ray to the active energy curable composition of claim 1 to cause the active energy ray composition to cure. 14. A processed product, produced by a method comprising: stretching-processing or punching-processing the cured product of claim 13 . 15. The active energy ray curable composition of claim 5 , wherein the second monofunctional monomer includes an alicyclic acrylate or an alicyclic methacrylate. 16. The active energy ray curable composition of claim 1 , wherein the first monofunctional monomer having a polar group is selected from acryloyl morpholine, methacryloyl morpholine, dimethyl acrylamide, isopropyl acrylamide, hydroxyethyl acrylamide, hydroxyethyl methacrylamide, and dimethylamino propyl acrylamide; and the second monofunctional monomer having no polar group is selected from isobornyl acrylate, isobornyl methacrylate, adamantyl acrylate, adamantyl methacrylate, 2-methyl-2-adamantyl acrylate, 2-methyl-2-adamantyl methacrylate, dicyclopentenyl acrylate, dicyclopentenyl methacrylate, dicyclopentanyl acrylate, dicyclopentanyl methacrylate, 3,3,5-trimethylcyclohexane acrylate, 3,3,5-trimethylcyclohexane methacrylate, and t-butyl methacrylate.

Assignees

Inventors

Classifications

  • by a heterocyclic ring containing nitrogen · CPC title

  • C09D11/101Primary

    Inks specially adapted for printing processes involving curing by wave energy or particle radiation, e.g. with UV-curing following the printing · CPC title

  • Inkjet printing inks · CPC title

  • Esters · CPC title

  • Amides {, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide} · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9790381B2 cover?
An active energy ray curable composition is provided. The active energy ray curable composition includes polymerizable compounds including a first monofunctional monomer having a polar group, a second monofunctional monomer having no polar group, and a polyfunctional monomer. The homopolymer of each of the first monofunctional monomer and the second monofunctional monomer has a glass transition…
Who is the assignee on this patent?
Arita Manabu, Yoshino Mie, Ricoh Co Ltd
What technology area does this patent fall under?
Primary CPC classification C09D11/101. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Oct 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).